Trials / Completed
CompletedNCT00793910
Oral Gabapentin Versus Placebo for Treatment of Postoperative Pain Following Photorefractive Keratectomy
Oral Gabapentin Versus Placebo for Treatment of Postoperative Pain Following Photorefractive Keratectomy: A Randomized, Double-masked, Single Center, Placebo-controlled Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 106 (actual)
- Sponsor
- Walter Reed Army Medical Center · Federal
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the effectiveness of an oral medication called gabapentin in reducing pain after Photorefractive Keratectomy (PRK) eye surgery and to assess the frequency of use of rescue medication interventions, defined as non-steroidal anti-inflammatory (NSAID) eye drops and oral narcotic medication.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gabapentin | Gabapentin 300 mg taken by mouth thrice daily for 7 days |
| DRUG | placebo | placebo (sugar pill) taken by mouth thrice daily for 7 days |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2008-11-19
- Last updated
- 2014-07-16
- Results posted
- 2012-02-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00793910. Inclusion in this directory is not an endorsement.